Drug resistance
Key facts
- A few organisms naturally resist any one drug before treatment, so treating with a single drug lets them take over.
- Failure to treat the first episode properly is the commonest cause of MDR and XDR tuberculosis.
- MDR resists isoniazid and rifampicin; XDR adds a fluoroquinolone and bedaquiline or linezolid.
Resistance starts in one patient's lesion and then spreads to other people.
How drug-resistant tuberculosis develops
- Resistant organisms exist before treatment. Any large population of M. tuberculosis holds a few organisms that are naturally resistant to any one drug. They are present before any drug is given.
- Monotherapy selects them. When treatment is inadequate, especially with a single drug, the resistant organisms take over the population. This was first seen in patients given streptomycin alone.
- The resistant population regrows. The survivors multiply back to the original number, and the whole population is now resistant. Clinically this looks like relapse.
- Resistant organisms spread. The next person inhales resistant organisms and has resistant disease from the start, without taking any drug. Failure to treat the first episode properly is the commonest cause of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis.